Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Linear atrophoderma of Moulin (LAM) is characterized by mildly atrophic and hyperpigmented band-like lesions that follow the lines of Blaschko on the trunk or limbs. Since its initial description in 1992, less than 30 cases have been reported in the literature. Onset occurs during childhood or adolescence and the disease is non-progressive. There is no prior inflammation or subsequent scleroderma. The etiology is unknown but as LAM follows the lines of Blaschko it has been suggested that the disease is caused by mosaicism of a predisposing gene.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for linear atrophoderma of Moulin.
4 publications have been identified in PubMed for linear atrophoderma of Moulin. Research spans Case Report / Case Series (100%).
Hussein Al-Janabi M (2024). [PMID: 39355723](https://pubmed.ncbi.nlm.nih.gov/39355723/). *Skin Health Dis*. [Case Report / Case Series]
Ertop Doğan P (2024). [PMID: 38511542](https://pubmed.ncbi.nlm.nih.gov/38511542/). *Int J Dermatol*. [Case Report / Case Series]
Duwal A (2024). [PMID: 39369419](https://pubmed.ncbi.nlm.nih.gov/39369419/). *JNMA J Nepal Med Assoc*. [Case Report / Case Series]
Paradisi A (2024). [PMID: 38711276](https://pubmed.ncbi.nlm.nih.gov/38711276/). *J Dermatol*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 7:50 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center